Personalized Targeted Immunomodulation in COVID-19 ARDS

Conditions: COVID-19 Acute Respiratory Distress Syndrome Interventions: Drug: Single target immunomodulation; Drug: Standard of care Sponsors: Erasmus Medical Center; Amsterdam UMC; Leiden University Medical Center; St. Antonius Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials